Platelet count at baseline (Plt) and outcomes in patients (pts) with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S) in CALGB80802 (Alliance) (C8).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ghassan K. Abou-Alfa, Qian Shi, Jennifer J. Knox, Andreas Kaubisch, James Posey, Benjamin R. Tan, Petr Kavan, Rakesh Goel, Philip Edward Lammers, Tanios S. Bekaii-Saab, Vincent C. Tam, Lakshmi Rajdev, Robin Kate Kelley, Abby B. Siegel, Tyler Zemla, Imane H. El Dika, Alan P. Venook, Monica M. Bertagnolli, Jeffrey A. Meyerhardt, Eileen Mary O'Reilly
Institutions: Memorial Sloan Kettering Cancer Center, Mayo Clinic, Princess Margaret Cancer Centre, Albert Einstein College of Medicine, Montefiore Medical Center, University of Alabama at Birmingham, Washington University in St. Louis, McGill University, Ottawa Hospital, Meharry Medical College, Mayo Clinic Hospital, University of Calgary, University of California, San Francisco, Columbia University, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890738218